期刊文献+

化痰通络组方联合依达拉奉治疗进展性脑梗死临床观察 被引量:5

下载PDF
导出
摘要 目的观察化痰通络组方联合依达拉奉对进展性脑梗死的临床疗效。方法将患者随机分为两组,均给予常规神经内科治疗。治疗组加用化痰通络组方口服及依达拉奉入液静滴;对照组予依达拉奉入液静滴。15 d后观察疗效。结果治疗组总有效率高于对照组,神经功能缺损程度改善优于对照组。结论化痰通络组方联合依达拉奉治疗进展性性脑梗死的疗效显著且无毒副作用。
出处 《中国中医急症》 2012年第11期1823-1824,共2页 Journal of Emergency in Traditional Chinese Medicine
  • 相关文献

参考文献6

  • 1黄如训.进展性脑梗死的发病机制和危险因素[J].国外医学:脑血管病分册,2003:15(1):3-6.
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33008
  • 3Matsumoto N, Kimura K, YokotaC, et al. Early neurological deteriora- tion represent attack in acute small non-lacunarstroke [ J ]. Neurol Sci, 2004,217(2) : 151-155.
  • 4杨树德,薛轴,杨金菊.中西医结合对中风理论与治则的新认识[J].中国中西医结合杂志,1992,12(2):111-112. 被引量:78
  • 5Edaravone Acutelnfarction Study Group. Effect of novel free radical cavenger,edaravone (MCI-186),on acute brain infarction. Random- ized, placebo -controlled, double -blind study at multicenters [J ]. Cerebrobasc Dis, 2003,15 (2) : 2222.
  • 6狄晴,葛剑青,陈道文,徐肖,陈惠玲,过燕萍,李继民,石静萍,张颖冬,李作汉.依达拉奉治疗急性脑梗死的临床观察[J].临床神经病学杂志,2004,17(3):184-186. 被引量:303

二级参考文献6

  • 1Jain KK. Neuroprotection in cerebrovascular disease. Expert Opin Investig Drugs, 2000,9:695
  • 2Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent. Nippon Yakurigaku Zasshi, 2002, 119:301
  • 3Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis, 2003, 15:222
  • 4Tabrizchi R. Edaravone Mitsubishi-Tokyo. Curr Opin Investig Drugs, 2000,1:347
  • 5Jin YJ, Mima T, Raicu V, et al. Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils. Neurosci Res, 2002,43:75
  • 6Tanahashi N, Fukuuchi Y. Treatment of acute ischemic stroke: recent progress. Intern Med, 2002, 41:337

共引文献33292

同被引文献75

  • 1严浩成,李国菁,王行宽.补肾益气活血法治疗缺血性中风的研究概况[J].新中医,2005,37(2):89-91. 被引量:36
  • 2中风病诊断与疗效评定标准(试行)[J].北京中医药大学学报,1996,19(1):55-56. 被引量:5961
  • 3周仲瑛.中风辨治述要[J].浙江中医杂志,2006,41(10):566-568. 被引量:10
  • 4陈灏珠.实用内科学[M]11版[M].北京:人民卫生出版社,2001.957-959.
  • 5Bots ML. Ford I. Lloyd SM. et al. progression in patients with eerebrovaseular disease of ischemie origin: a randomized controlled trial [J]. Stroke, 2014Aug, 45 (8): 2348 -53.
  • 6Vila N,Castillo J,Divalos A,et al.Levels of anti inflammatory cytokines and neurological worsening in acute ischemic stroke[J].Stroke,2003,34:671-675.
  • 7中华中医药协会.中国内科常见病临床诊疗指南[M].北京:中国中医药出版社,2008.
  • 8Boxerman JL,Jayaraman MV,Mehan WA,et al.Clinical stroke penumbra:use of National Institutes of Health stroke scale as a surrogate for CT perfusion in patient triage for intraarterial middle cerebral artery stroke therapy[J].AJNR Am J Neuroradiol,2012,33(10):1893-1900.
  • 9Cha MH,Jones AD,Ko MM,et al.Metabolic profiles distinguish Non-Dampness-Phlegm and Dampness-Phlegm patterns among Korean Patients with acute cerebral infarction[J].Evid Based Complement Alternat Med,2013,2013:517018.
  • 10Lin K,Zink WE,Tsiouris AJ,et al.Risk assessment of hemorrhagic transformation of acute middle cerebral artery stroke using multimodal CT[J].J Neuroimaging,2012,22(2):160-166.

引证文献5

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部